Parkway Wealth Management Group LLC Makes New $26.45 Million Investment in SPDR S&P Biotech ETF $XBI

Parkway Wealth Management Group LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 167,759 shares of the exchange traded fund’s stock, valued at approximately $26,452,000. SPDR S&P Biotech ETF comprises about 3.0% of Parkway Wealth Management Group LLC’s investment portfolio, making the stock its 7th largest position. Parkway Wealth Management Group LLC owned about 0.24% of SPDR S&P Biotech ETF as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Kercheville Advisors LLC grew its position in SPDR S&P Biotech ETF by 14.2% during the third quarter. Kercheville Advisors LLC now owns 28,304 shares of the exchange traded fund’s stock valued at $4,463,000 after buying an additional 3,509 shares during the period. New Wave Wealth Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 158.4% during the third quarter. New Wave Wealth Advisors LLC now owns 3,695 shares of the exchange traded fund’s stock worth $542,000 after buying an additional 2,265 shares during the last quarter. Cornell Pochily Investment Advisors Inc. increased its holdings in SPDR S&P Biotech ETF by 21.9% during the third quarter. Cornell Pochily Investment Advisors Inc. now owns 1,919 shares of the exchange traded fund’s stock worth $303,000 after buying an additional 345 shares during the last quarter. IFP Advisors Inc increased its holdings in SPDR S&P Biotech ETF by 4.7% during the third quarter. IFP Advisors Inc now owns 22,189 shares of the exchange traded fund’s stock worth $3,499,000 after buying an additional 997 shares during the last quarter. Finally, Robertson Stephens Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 0.5% in the third quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock worth $3,412,000 after acquiring an additional 99 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $147.86 on Tuesday. The firm has a market cap of $10.21 billion, a price-to-earnings ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 52 week low of $106.30 and a 52 week high of $169.89. The firm’s 50-day simple moving average is $157.89 and its two-hundred day simple moving average is $147.21.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.